Psychoactive Medication Quality Assurance Rating Survey (PQRS)

Journal of Developmental and Physical Disabilities

Volumn 9, Issue 4, 1997, Pages 311-336

  Brasic, James R ^a   Young, J Gerald ^a,c   Furman, Jasmin ^b,c   Conte, Rafael M ^d,e   Baisley, William E ^f   Jaslow, Robert I ^g  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Child and Adolescent Program   (United States)

^e MIAMI CHILDREN'S HOSPITAL   (United States)

^f Pharmacy   (United States)

^g NONE

Author keywords

Chart review; Illness; Medications; Mental; Psychoactive; Quality assurance; Surveys

Indexed keywords

EID: 0031326173     PISSN: 1056263X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024925927880     Document Type: Review

References (72)

1. Americans with Disabilities Act of 1990, 42 U.S.C.A. § 12101 et seq. (West 1995).
2. American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.), American Psychiatric Association, Washington, DC.
3. Ashton-Tate Corporation. (1988). dBASEIV, Ashton-Tate Corporation, Torrance, California.
4. Best-Sigford, B., Bruininks, R. H., Lakin, K. C., Hill, B. K., and Heal, L. W. (1982). Resident release patterns in a national sample of public residential facilities. Am. J. Ment. Def. 87(2): 130-140.
5. Brasic, J. R., and Young, J. G. (1994). Research design, measures, and statistics. In Robson, K. S. (ed.), Manual of Clinical Child and Adolescent Psychiatry (rev. ed.), American Psychiatric Press, Inc., Washington, DC, pp. 435-463.
6. Bruininks, R. H., Hauber, F. A., and Kudla, M. J. (1980). National survey of community residential facilities: a profile of facilities and residents in 1977. Am. J. Ment. Def. 84(5): 470-478.
7. Bruininks, R. H., Hill, B. K., and Thorsheim, M. J. (1982). Deinstitutionalization and foster care for mentally retarded people. Health Social Work 7: 198-205.
8. Bruininks, R. H., Kudla, M. J., Wieck, C. A., and Hauber, F. A. (1980). Management problems in community residential facilities. Ment. Retard. 18(3): 125-130.
9. Byalin, K. (1992). The quality assurance dilemma in psychiatry: a sociological perspective. Commun. Ment. Health J. 28(5): 453-459.
10. Cicchetti, D. V. (1988). When diagnostic agreement is high, but reliability is low: some paradoxes occurring in joint independent neuropsychology assessments. J. Clin. Exp. Neuropsychol. 10(5): 605-622.
11. Cicchetti, D. V., and Feinstein, A. R. (1990). High agreement but low kappa: II. Resolving the paradoxes. J. Clin. Epidemiol. 43(6): 551-558.
12. Cicchetti, D. V., Sparrow, S. S., Volkmar, F., Cohen, D., and Rourke, B. P. (1991). Establishing the reliability and validity of neuropsychological disorders with low base rates: some recommended guidelines. J. Clin. Exp. Neuropsychol. 13(2): 328-338.
13. Civil Rights of Institutionalized Persons Act of 1980, Pub. L. No. 96-247, § 2, 94 Stat. 49 (1980).
14. Civil Rights of Institutionalized Persons Act of 1980, 42 U.S.C.A. § 1997 et seq. (West 1994).
15. Cornwell, J. K. (1988). CRIPA: the failure of federal intervention for mentally retarded people. Yale Law J. 97: 845-862.
16. Davis, J. M. (1976). Comparative doses and costs of antipsychotic medication. Arch. Gen. Psychiatry 33: 858-861.
17. Donabedian, A. (1986). Criteria and standards for quality assessment and monitoring. QRB: Quality Rev. Bull. 12: 99-108.
18. Drug Facts and Comparisons, 1991 Edition. (1990). J. B. Lippincott Company, Saint Louis.
19. Feinstein, A. R., and Cicchetti, D. V. (1990). High agreement but low kappa: I. The problems of two paradoxes. J. Clin. Epidemiol. 43(6), 543-549.
20. Field, M. J. (Ed.). (1995). Setting Priorities for Clinical Practice Guidelines, National Academy Press, Washington, D.C.
21. Fleiss, J. L. (1981). Statistical Methods for Rates and Proportions (2nd ed.), Wiley, New York.
22. Gadow, K. D. (1985). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacol. Bull. 21(2): 291-303.
23. Gaucher, E. J., and Coffey, R. J. (1993). Total Quality in Healthcare: From Theory to Practice, Jossey-Bass Publishers, San Francisco.
24. George, J. (1994). Mental health, mental retardation, and the law: a conference. Ment. Phys. Disabil. Law Rep. 10(5): 404.
25. Goonan, K. J. (1995). The Juran Prescription: Clinical Quality Management, Jossey-Bass Publishers, San Francisco.
26. Griffiths, D. (1989). Quality assurance for behavior interventions. Psychiatric Aspects Ment. Retard. Rev. 8(11): 73-80.
27. Gross, E. J., Maguire, K. B., Shepard, S. M., and Piersel, W. C. (1994). Development and evaluation of the Active Treatment Client Rights Checklist. Res. Devel. Disabil. 15(1): 1-18.
28. Gualtieri, C. T., and Sprague, R. L. (1985). Preventing tardive dyskinesia and preventing tardive dyskinesia litigation. Psychopharmacol. Bull. 20(3): 346-348.
29. Hartmann, D. P. (1977). Considerations in the choice of interobserver reliability estimates. J. Appl. Behav. Anal. 10: 103-116.
30. Hauber, F. A., Bruininks, R. H., Hill, B. K., Lakin, K. C., Scheerenberger, R. C., and White, C. C. (1984). National census of residential facilities: a 1982 profile of facilities and residents. Am. J. Ment. Def. 89(3): 236-245.
31. Hill, B. K., Balow, E. A., and Bruininks, R. H. (1985). A national survey of prescribed drugs in institutions and community residential facilities for mentally retarded people. Psychopharmacol. Bull. 21(2): 279-284.
32. Hill, B. K., Bruininks, R. H., and Lakin, K. C. (1983). Characteristics of mentally retarded people in residential facilities. Health Social Work 8: 85-95.
33. ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification, Fourth Edition, 1994. (1993). Practice Management Information Corporation (PMIC), Los Angeles.
34. Jeste, D. V., and Wyatt, R. J. (1985). Prevention and management of tardive dyskinesia. J. Clin. Psychiatr. 46(4, section 2), 14-18.
35. Joint Commission on Accreditation of Healthcare Organizations. (1986). Consolidated Standards Manual, 1987 Edition, Joint Commission on Accreditation of Healthcare Organizations, Chicago.
36. Joint Commission on Accreditation of Healthcare Organizations. (1987). AHC/88: Ambulatory Health Care Standards Manual, Joint Commission on Accreditation of Healthcare Organizations, Chicago.
37. Joint Commission on Accreditation of Healthcare Organizations. (1992). MHM: 1993 Accreditation Manual for Mental Health, Chemical Dependency, and Mental Retardation/Developmental Disabilities Services. Volume 1: Standards. Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, Illinois.
38. Joint Commission on Accreditation of Healthcare Organizations. (1993). 1994 Accreditation Manual for Ambulatory Health Care, Volume I: Standards. Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL.
39. Kalachnik, J. E., Larum, J. G., and Swanson, A. (1983). A tardive dyskinesia monitoring policy for applied facilities. Psychopharmacol. Bull. 19(2): 277-282.
40. Kalachnik, J. E., Young, R. C., and Offerman, D. (1984). A tardive dyskinesia evaluation and diagnosis form for applied facilities. Psychopharmacol. Bull. 20(2): 303-307.
41. Kane, J. M., Evans, D. L., Fiester, S. J., Mirin, S. M., Pincus, H. A., and Schatzberg, A. F. (1992). Psychopharmacological screening criteria. In American Psychiatric Association Committee on Quality Assurance. Manual of Psychiatric Quality Assurance: A Report of the American Psychiatric Association Committee on Quality Assurance. American Psychiatric Association Committee on Quality Assurance, Washington, DC, pp. 189-205.
42. Kazandjian, V. A. (with Sternberg, E. L.). (1995). The Epidemiology of Quality, Aspen Publishers, Gaithersburg, MD.
43. Kirk, S. A., and Kutchins, H. (1992). The Selling of DSM: The Rhetoric of Science in Psychiatry, Aldine de Gruyter, New York.
44. Kritchevsky, S. B., and Simmons, B. P. (1991). Continuous quality improvement: Concepts and applications for physician care. J. Am. Med. Assoc. 226: 1817-1823.
45. Kunjukrishnan, R., and Varan, L. R. (1989). Interface between mental subnormality and law - a review. Psychiatric J. Univ. Ottawa 14(3): 439-452.
46. Lakin, K. C., Hill, B. K., Hauber, F. A., and Bruininks, R. H. (1982b). Changes in age at first admission to residential care for mentally retarded people. Ment. Retard. 20(5): 216-219.
47. Lakin, K. C., Hill, B. K., Hauber, F. A., Bruininks, R. H., and Heal, L. W. (1983). New admissions and readmissions to a national sample of public residential facilities. Am. J. Ment. Def. 88(1): 13-20.
48. Lakin, K. C., Krantz, G. C., Bruininks, R. H., Clumpner, J. L., and Hill, B. K. (1982a). One hundred years of data on populations of public residential facilities for mentally retarded people. Am. J. Ment. Def. 87(1): 1-8.
49. Mills, M. J., Norquist, G. S., Shelton, R. C., Gelenberg, A. J., and Van Putten, T. (1986). Consent and liability with neuroleptics: the problem of tardive dyskinesia. Int. J. Law Psychiatry 8: 243-252.
50. Morgan, R. L., Striefel, S., Baer, R., and Percival, G. (1991). Regulating behavioral procedures for individuals with handicaps: review of state department standards. Res. Devel. Dis. 12: 63-85.
51. Pary, R. J. (1995). Discontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illness. Am. J. Ment. Retard. 100: 207-212.
52. Physicians' Desk Reference (PDR). (1990). (44th ed.). Medical Economics Company, Inc., Oradell, NJ.
53. Poling, A., and LeSage, M. (1995). Evaluating psychotropic drugs in people with mental retardation: where are the social validity data? Am. J. Ment. Retard. 100: 193-200.
54. Post, R. M., Leverich, G. S., Altshuler, L., and Mikalauskas, K. (1992). Lithium-discontinuation-induced refractoriness: preliminary observations. Am. J. Psychiatry 149: 1727-1729.
55. Price, S. B., and Greenwood, S. K. (1988). Using treatment plans for quality assurance monitoring in a residential center. Qual. Rev. Bull. 14(9): 266-274.
56. Rotegard, L. L., Bruininks, R. H., and Krantz, G. C. (1984). State operated residential facitilities for people with mental retardation July 1, 1978-June 30, 1982. Ment. Retard. 22(2): 69-74.
57. Rotegard, L. L., Hill, B. K., and Bruininks, R. H. (1983). Environmental characteristics of residential facilities for mentally retarded persons in the United States. Am. J. Ment. Def. 88(1): 49-56.
58. Shrout, P. E., Spitzer, R. L., and Fleiss, J. L. (1987). Quantification of agreement in psychiatric diagnosis revisited. Arch. Gen. Psychiatry 44: 172-177.
59. Sovner, R., and Hurley, A. D. (1985). Assessing the quality of psychotropic drug regimens prescribed for mentally retarded persons. Psychiatric Aspects Ment. Retard. Rev. 8/9: 31-38.
60. Sovner, R., and Hurley, A. D. (1987). Objective behavioral monitoring of psychotropic drug therapy. Psychiatric Aspects Ment. Retard. Rev. 6(10): 47-51.
61. Spitzer, R. L., and Fleiss, J. L. (1974). A re-analysis of the reliability of psychiatric diagnosis. Brit. J. Psychiatry 125: 341-347.
62. Spitznagel, E. L, and Heizer, J. E. (1985). A proposed solution to the base rate problem in the kappa statistic. Arch. Gen. Psychiatry 42: 725-728.
63. Sprague, R. L., White, D. M., Ullmann, R., & Kalachnik, J. E. (1984). Methods for selecting items in a tardive dyskinesia rating scale. Psychopharmacol. Bull. 20(3): 339-345.
64. Staff of the Division of Education and the Division of Accreditation, Joint Commission on Accreditation of Hospitals (1986). Monitoring and evaluation of the quality and appropriateness of care: a hospital example. Quality Rev. Bull. 12: 326-330.
65. U.S. v. Com. of Pa., 832 F. Supp. 122 (E.D. Pa. 1993).
66. U.S. v. State of Ill., 148 F.R.D. 587 (N.D. Ill. 1993).
67. White, C. C., Hill, B. K., Lakin, K. C., and Bruininks, R. H. (1984). Day programs of adults with mental retardation in residential facilities. Ment. Retard. 22(3): 121-127.
68. Wilkinson, L. (1988). SYSTAT: The System for Statistics. SYSTAT, Inc., Evanston, IL.
69. Wilmotte, J. (1989). Assessment of quality control in the use of psychotropics for the treatment of depression: a brief review. Neuropsychobiology 22: 208-213.
70. Wyatt by and through Rawlins v. Poundstone, 892 F. Supp. 1410 (M.D. Ala. 1995).
71. Wyatt v. Poundstone, No. 3195-N, 1995 U.S. Dist. LEXIS 10289, at *16 (M.D. Ala. July 11, 1995).
72. Wyatt v. Poundstone, No. 3195-N, 1995 U.S. Dist. LEXIS 13762, at *18 (M.D. Ala. April 18, 1995).